CYP 2.13% 24.0¢ cynata therapeutics limited

Ann: Letter to Optionholders, page-80

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 19,349 Posts.
    lightbulb Created with Sketch. 6439
    If the market turns against stem cell companies it is not going to be good for CYP no matter how promising any treatments they have. The best outcome for CYP would be for MSB to actually succeed at something other than BSing the market.


    I think we agree on SI.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.